Related references
Note: Only part of the references are listed.Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Sean J. Whittaker et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy
Anja Schirbel et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
New pathophysiological insights and modern treatment of IBD
Matthias A. Engel et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Biological Therapies for Inflammatory Bowel Diseases
Paul Rutgeerts et al.
GASTROENTEROLOGY (2009)
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
R. Glauben et al.
GUT (2008)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Enhanced histone acetylation and transcription: A dynamic perspective
Alison L. Clayton et al.
MOLECULAR CELL (2006)
Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src
M. S. Longworth et al.
ONCOGENE (2006)
Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease
J Maul et al.
GASTROENTEROLOGY (2005)
Matrix metalloproteinases and the gut - new roles for old enzymes
SL Pender et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Class II histone deacetylases: versatile regulators
E Verdin et al.
TRENDS IN GENETICS (2003)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease
RB Heuschkel et al.
GUT (2000)
Share Paper
